A detailed history of Invesco Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Invesco Ltd. holds 810,301 shares of IONS stock, worth $28.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
810,301
Previous 968,917 16.37%
Holding current value
$28.9 Million
Previous $46.2 Million 29.71%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$40.06 - $51.86 $6.35 Million - $8.23 Million
-158,616 Reduced 16.37%
810,301 $32.5 Million
Q2 2024

Aug 13, 2024

BUY
$36.45 - $47.7 $19.2 Million - $25.1 Million
526,030 Added 118.77%
968,917 $46.2 Million
Q1 2024

May 14, 2024

BUY
$42.03 - $53.55 $9.96 Million - $12.7 Million
236,986 Added 115.1%
442,887 $19.2 Million
Q4 2023

Feb 12, 2024

BUY
$43.39 - $51.63 $3.24 Million - $3.86 Million
74,734 Added 56.98%
205,901 $10.4 Million
Q3 2023

Nov 13, 2023

BUY
$38.5 - $47.13 $55,786 - $68,291
1,449 Added 1.12%
131,167 $5.95 Million
Q2 2023

Aug 11, 2023

SELL
$34.73 - $43.33 $6.46 Million - $8.06 Million
-186,002 Reduced 58.91%
129,718 $5.32 Million
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $225,892 - $277,152
-6,727 Reduced 2.09%
315,720 $11.3 Million
Q4 2022

Feb 13, 2023

BUY
$37.12 - $46.52 $1.01 Million - $1.27 Million
27,248 Added 9.23%
322,447 $12.2 Million
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $1.12 Million - $1.5 Million
-30,786 Reduced 9.44%
295,199 $13.1 Million
Q2 2022

Aug 15, 2022

BUY
$31.71 - $43.0 $5.9 Million - $8 Million
185,993 Added 132.86%
325,985 $12.1 Million
Q1 2022

May 16, 2022

BUY
$29.88 - $37.04 $231,570 - $287,060
7,750 Added 5.86%
139,992 $5.19 Million
Q4 2021

Feb 14, 2022

SELL
$25.61 - $35.1 $233,383 - $319,866
-9,113 Reduced 6.45%
132,242 $4.02 Million
Q3 2021

Nov 15, 2021

SELL
$33.54 - $40.55 $6.68 Million - $8.08 Million
-199,258 Reduced 58.5%
141,355 $4.74 Million
Q2 2021

Aug 17, 2021

SELL
$34.54 - $47.25 $69.7 Million - $95.4 Million
-2,018,821 Reduced 85.56%
340,613 $13.6 Million
Q1 2021

May 17, 2021

SELL
$42.51 - $63.78 $43.6 Million - $65.4 Million
-1,025,435 Reduced 30.29%
2,359,434 $106 Million
Q4 2020

Feb 16, 2021

BUY
$45.3 - $60.27 $36.8 Million - $49 Million
813,228 Added 31.62%
3,384,869 $191 Million
Q3 2020

Nov 16, 2020

BUY
$47.45 - $62.95 $11 Million - $14.6 Million
231,896 Added 9.91%
2,571,641 $122 Million
Q2 2020

Aug 14, 2020

SELL
$46.85 - $61.05 $49,286 - $64,224
-1,052 Reduced 0.04%
2,339,745 $138 Million
Q1 2020

May 15, 2020

SELL
$41.6 - $63.4 $591,926 - $902,118
-14,229 Reduced 0.6%
2,340,797 $111 Million
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $1.17 Million - $1.41 Million
-21,637 Reduced 0.91%
2,355,026 $142 Million
Q3 2019

Nov 14, 2019

BUY
$59.06 - $72.15 $6.21 Million - $7.58 Million
105,124 Added 4.63%
2,376,663 $142 Million
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $136 Million - $189 Million
2,191,974 Added 2754.95%
2,271,539 $146 Million
Q1 2019

May 15, 2019

BUY
$52.92 - $81.17 $1.57 Million - $2.4 Million
29,583 Added 59.19%
79,565 $6.46 Million
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $2.17 Million - $2.98 Million
49,982 New
49,982 $2.7 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.06B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.